Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients
Identification of sex differences in factors associated with non-persistence makes it possible to determine the groups of patients in whom special attention should be paid to improving their persistence with a combination of medicines in order to ensure successful secondary prevention of PAD.
Authors
- Tomáš Tesař (ORCID: https://orcid.org/0000-0002-0023-4574)
- Emma Aarnio (ORCID: https://orcid.org/0000-0002-6555-7833)
- Martin Wawruch (ORCID: https://orcid.org/0000-0001-7672-1574)
- Miriam Petrová (ORCID: https://orcid.org/0000-0001-5609-135X)
- Denisa Čelovská
- Michal Trnka (ORCID: https://orcid.org/0000-0003-4599-1971)
- Sofa D. Alfian (ORCID: https://orcid.org/0000-0001-5419-8938)
- Ján Murín
- Tomas Paduch
Institutions
- University of Eastern Finland (FI)
- Masaryk University (CZ)
- St. Anne's University Hospital Brno (CZ)
- Comenius University Bratislava (SK)
- Padjadjaran University (ID)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fphar.2024.1464689
- Citations
- 4
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- Suomen Kulttuurirahasto
- Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV